| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 759 | 21.840 | 44.357 | 70.925 | 148.443 | 192.954 |
| Total Income - EUR | - | - | - | - | 794 | 30.121 | 44.623 | 70.926 | 148.529 | 193.960 |
| Total Expenses - EUR | - | - | - | - | 4.039 | 21.793 | 29.900 | 58.421 | 58.988 | 85.441 |
| Gross Profit/Loss - EUR | - | - | - | - | -3.246 | 8.328 | 14.722 | 12.505 | 89.541 | 108.518 |
| Net Profit/Loss - EUR | - | - | - | - | -3.253 | 8.027 | 14.276 | 11.795 | 88.056 | 102.699 |
| Employees | - | - | - | - | 2 | 3 | 4 | 6 | 6 | 7 |
Check the financial reports for the company - Giaclinik S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 3.525 | 21.971 | 72.172 | 114.599 | 359.732 |
| Current Assets | - | - | - | - | 13.571 | 24.027 | 15.895 | 18.675 | 39.474 | 270.162 |
| Inventories | - | - | - | - | 13.467 | 14.368 | 14.607 | 15.529 | 17.901 | 18.499 |
| Receivables | - | - | - | - | 34 | 6.546 | 315 | 2.715 | 17.096 | 13.068 |
| Cash | - | - | - | - | 71 | 3.113 | 973 | 431 | 4.477 | 238.595 |
| Shareholders Funds | - | - | - | - | -3.211 | 4.856 | 19.024 | 30.878 | 118.836 | 220.582 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 16.783 | 22.696 | 29.345 | 59.969 | 35.727 | 409.800 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Giaclinik S.r.l.